• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Emerging Biopharma

Biotech

Drug discovery biotech Vyant preps to wind down operations

Vyant Bio is winding down operations, including reducing its workforce, pursuing strategic alternatives and saying goodbye to CEO John Roberts.
Annalee Armstrong Feb 3, 2023 10:14am

Days after halting leukemia drug, Magenta to close its doors

Feb 2, 2023 5:06pm

Purple snags Immunorizon's tri-specific antibodies in small M&A

Feb 2, 2023 10:20am

Layoffs still battering biotech, with Big Pharmas piling on pain

Feb 1, 2023 10:50am

More layoffs at Instil as cell therapy production shifts to UK

Feb 1, 2023 10:15am

Despite blockbuster Altos funds, longevity investment falls $1B

Jan 31, 2023 11:28am
More News

UniQure snags rare ALS therapy from Apic Bio for $10M upfront

Jan 31, 2023 10:45am

Structure finalizes $111M IPO; Intensity plots offering

Jan 30, 2023 10:59am

Fierce Biotech Fundraising Tracker: Ribon, Grey Wolf and more

Jan 30, 2023 9:36am

10 top M&A targets in biotech for 2023

Jan 30, 2023 3:00am
See more
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy